Pfizer Inc. (PFE.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 141.98B |
| Enterprise Value | 210.55B |
| P/E Ratio | 41.54 |
| PEG Ratio | -0.7 |
| Price/Sales Ratio | 2.63 |
| Price/Book Ratio | 1.88 |
| Enterprise/Revenue | 3.59 |
| Enterprise/EBITDA | 16.94 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.24 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 62.58B |
| Revenue/Share | 11.16 |
| Gross Profit | 46.52B |
| EBITDA | 16.78B |
| Net Income | 7.77B |
| Diluted EPS | 1.36 |
Balance Sheet
| Total Cash | 14.07B |
| Total Cash/Share | 2.5 |
| Total Debt | 61.8B |
| Total Debt/Equity | 0.7 |
| Current Ratio | 1.42 |
| Book Value Per Share | 15.67 |
Price History
| 52-Week Change | 22.24 |
| 52-Week High | 28.03 |
| 52-Week Low | 20.72 |
| Moving Average 50 Days | 25.4 |
| Moving Average 200 Days | 23.38 |
Statistics
| Average Volume | 39,364 |
| Shares Outstanding | 5.7B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.72 |
| Trailing Annual Dividend Yield | 5.86 |
| Payout Ratio | 2.43 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
